Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA, NDC#66689-307-08.
Published November 15, 2023 · Recall initiated: October 26, 2023
Summary
FDA records drug Class III recall D-0093-2024, published November 15, 2023 and initiated October 26, 2023. Recalling firm: VistaPharm LLC; Status: Terminated; Reported quantity: 11,633 bottles; Lot: Lot #: M23400A, M23401A, M23402A, Exp Date. 04/30/2025; M23591A, M23592A, Exp Date. 06/30/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.
What to do
Voluntary: Firm initiated · Letter
Get an email if MYCOPHENOLATE MOFETIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MYCOPHENOLATE MOFETIL
- Manufacturer
- VistaPharm LLC
- Distributor
- Nationwide and Saudi Arabia
- Lot
- Lot #: M23400A, M23401A, M23402A, Exp Date. 04/30/2025; M23591A, M23592A, Exp Date. 06/30/2025.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only,September 9, 2026
- FDAMycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only,August 5, 2026
- FDARanolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: GlenmarkNovember 15, 2023
- FDAOxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla LifeNovember 15, 2023
- FDAClinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole Nitrate 2.0%November 15, 2023
- FDAMycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: ParMay 15, 2019
Questions about this recall
Was Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA, NDC#66689-307-08. recalled?
Yes. FDA published recall D-0093-2024 on November 15, 2023. Reported hazard: Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MYCOPHENOLATE MOFETIL.